MetaCap

CG Oncology Statistics

NASDAQ: CGONHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

79.47-2.43 (-2.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CG Oncology by the numbers

CG Oncology has a market capitalization of $7.10 billion based on 89.32M shares outstanding. With trailing EPS of $-2.76, CG Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 15.4% above its 50-day average and 17.9% above its 200-day average.

Average daily trading volume is 1.24M shares, or about $98.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CGON valuation vs. peer median

CGON compared with the median of 8 peer companies
MetricCGONPeer medianDifference
Market cap$7.10B$6.49B+9%
Avg. volume1.24M2.02M-39%

Peer median across 8 companies: TWST, IMVT, IBRX, KOD, SRRK, PCVX, KRYS, ADPT.

Valuation

Price / sales (latest FY)
1,756.97
EPS (TTM)
$-2.76

Price and trading

Previous close
81.90
Open
80.32
Day range
79.23 – 83.12
52-week range
37.01 – 93.95
52-week change
+87.25%
Beta
—
Volume
1.67M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
7.10B
Forward Pe
-26.91
Eps
-2.76
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
93.95
Week52 Low
37.01
Avg Volume
1.24M
Shares Outstanding
89.32M
Ma50
68.85
Ma200
67.40
Earnings Date
Nov 6, 2026
Pct From52w High
-15.41%
Pct From52w Low
114.73%

Related